PL1651287T3 - Iniekcyjny kompozyt do magnetocytolizy kostnych komórek przerzutu nowotworu - Google Patents

Iniekcyjny kompozyt do magnetocytolizy kostnych komórek przerzutu nowotworu

Info

Publication number
PL1651287T3
PL1651287T3 PL04767601T PL04767601T PL1651287T3 PL 1651287 T3 PL1651287 T3 PL 1651287T3 PL 04767601 T PL04767601 T PL 04767601T PL 04767601 T PL04767601 T PL 04767601T PL 1651287 T3 PL1651287 T3 PL 1651287T3
Authority
PL
Poland
Prior art keywords
magnetocytolysis
metastatic cells
bone metastatic
injectable composite
injectable
Prior art date
Application number
PL04767601T
Other languages
English (en)
Inventor
Patrick Pierre Frayssinet
Nicole Francine Rouquet
Original Assignee
Urodelia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urodelia filed Critical Urodelia
Publication of PL1651287T3 publication Critical patent/PL1651287T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
PL04767601T 2003-07-08 2004-07-07 Iniekcyjny kompozyt do magnetocytolizy kostnych komórek przerzutu nowotworu PL1651287T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0308332A FR2857268B1 (fr) 2003-07-08 2003-07-08 Composite injectable pour magnetocytolyse de cellules metastatiques osseuses
PCT/FR2004/001766 WO2005004942A2 (fr) 2003-07-08 2004-07-07 Composite injectable pour magnetocytolyse de cellules metastatiques osseuses
EP04767601A EP1651287B1 (fr) 2003-07-08 2004-07-07 Composite injectable pour magnetocytolyse de cellules metastatiques osseuses

Publications (1)

Publication Number Publication Date
PL1651287T3 true PL1651287T3 (pl) 2008-06-30

Family

ID=33522855

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04767601T PL1651287T3 (pl) 2003-07-08 2004-07-07 Iniekcyjny kompozyt do magnetocytolizy kostnych komórek przerzutu nowotworu

Country Status (10)

Country Link
US (1) US20070041908A1 (pl)
EP (1) EP1651287B1 (pl)
AT (1) ATE383175T1 (pl)
DE (1) DE602004011227T2 (pl)
DK (1) DK1651287T3 (pl)
ES (1) ES2297471T3 (pl)
FR (1) FR2857268B1 (pl)
PL (1) PL1651287T3 (pl)
PT (1) PT1651287E (pl)
WO (1) WO2005004942A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
FR2922454B1 (fr) * 2007-10-22 2010-01-01 Biomatlante Substitut osseux comprenant un agent de contraste, son procede de preparation et ses utilisations
CN102049066B (zh) * 2009-11-10 2013-12-25 中国医学科学院基础医学研究所 一种磁性复合材料及其在骨组织再生和修复中的应用
WO2013094722A1 (ja) * 2011-12-22 2013-06-27 オリンパス株式会社 癌細胞抑制セラミックスおよび癌細胞抑制セラミックスの製造方法、骨腫瘍の治療方法、粒径１～１０μｍのβリン酸三カルシウム多孔体顆粒の使用
CN102671245A (zh) * 2012-01-12 2012-09-19 河南科技大学 一种磁性骨水泥材料及磁性骨水泥的制备方法
CN104117098B (zh) * 2014-07-14 2016-03-30 上海师范大学 一种具有取向磁场的磁性羟基磷灰石/高分子三维多孔支架材料及其制备方法
CN114404655B (zh) * 2022-01-28 2022-12-20 洛阳市中医院 一种具有光热效应的多孔支架及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0288059A (ja) * 1988-09-26 1990-03-28 Univ Kyoto 温熱療法用セラミックス発熱体及びその製造方法
JP2979423B2 (ja) * 1990-02-13 1999-11-15 エヌオーケー株式会社 磁性微粒子の製造方法
US8333996B2 (en) * 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
AUPN978296A0 (en) * 1996-05-10 1996-05-30 Gray, Bruce N Targeted hysteresis hyperthermia as a method for treating cancer
JP3662347B2 (ja) * 1996-06-10 2005-06-22 日鉄鉱業株式会社 医療用粉体
FR2808026B1 (fr) * 2000-04-25 2002-06-14 Alexandre Laurent Biomateriau a base de polymere hydrophile presentant un signal specifique en imagerie par resonance magnetique et procede de preparation d'un tel biomateriau

Also Published As

Publication number Publication date
FR2857268A1 (fr) 2005-01-14
EP1651287A2 (fr) 2006-05-03
DE602004011227T2 (de) 2009-01-02
PT1651287E (pt) 2008-02-28
DE602004011227D1 (de) 2008-02-21
ES2297471T3 (es) 2008-05-01
FR2857268B1 (fr) 2007-09-21
DK1651287T3 (da) 2008-05-05
EP1651287B1 (fr) 2008-01-09
ATE383175T1 (de) 2008-01-15
US20070041908A1 (en) 2007-02-22
WO2005004942A2 (fr) 2005-01-20
WO2005004942A3 (fr) 2005-03-24

Similar Documents

Publication Publication Date Title
IL258880A (en) Diarylhydantoin compounds
PL1802625T3 (pl) Dwupodstawione pirazolobenzodiazepiny użyteczne jako inhibitory CDK2 i angiogenezy oraz w leczeniu raka sutka, okrężnicy, płuca i gruczołu krokowego
MX2009006627A (es) Quinazolinas para la inhibicion de pdk1.
CY1107862T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν παραγωγα οιστερολης για χρηση στη θεραπεια του καρκινου
TW200631917A (en) Synthetic aggregates comprising sewage sludge and other waste materials and methods for producing such aggregates
SE0104441L (sv) Keramiskt material, förfarande för framställning av keramiskt material och benimplantat, tandfyllnadsimplantat och biocement innefattande det keramiska materialet
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
NZ579478A (en) Epha3 antibodies for the treatment of solid tumors
MX2009009816A (es) Anticuerpos monoclonales para el tratamiento del cancer.
ATE468926T1 (de) Verwendung von hydrophobinen zur oberflächenbehandlung von gehärteten mineralischen baustoffen, naturstein, kunststein und keramiken
ATE507812T1 (de) Zahnzementsystem
PT1651287E (pt) Compósito injectável para magnetocitólise de células ósseas metastásicas
PL2021043T3 (pl) Wstrzykiwalny wypełniacz pustych przestrzeni w kościach
DE502007002510D1 (de) Keramische Einbettmasse zur Herstellung einer Giessform sowie damit verbundene Herstellungsverfahren
EA200702078A1 (ru) Способ обработки и строительства скважин
EA200600415A1 (ru) Проппанты и способ их изготовления
MY144317A (en) Treatment of polysilazane waste
DE202004016937U1 (de) Deponieabdeckung
ATE432933T1 (de) Flavopereirinderivate zur krebstherapie
AU2003267511A8 (en) Use of pthrp antagonists for treating renal cell carcinoma
PT1524250E (pt) Utilização de uma composição à base de ligantes endurecíveis em água ou ar para obtenção de um produto com o aspecto e as propriedades de uma pedra natural
TW200626150A (en) Use of Epothilones in the treatment of bone metastasis
GB0303376D0 (en) An improved injectable calcium phosphate bone cement
UA35082U (en) Building block hlynobit
UA42546U (ru) Огнестойкая композиционная бетонная смесь